Additional Information for Recombinant Antihemophilic Factor
Recombinant Antihemophilic Factor is a type of medication used to treat and prevent bleeding episodes in individuals with hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. It is classified under the supply class "Drugs And Biologicals" and belongs to the supply group "Medical, Dental, And Veterinary Equipment And Supplies."
Recombinant Antihemophilic Factor is produced using recombinant DNA technology, where the factor VIII protein is synthesized in a laboratory setting. This medication is designed to replace the missing or defective factor VIII in individuals with hemophilia A, allowing their blood to clot properly.
It is important to note that Recombinant Antihemophilic Factor is a prescription medication and should only be used under the guidance and supervision of a healthcare professional. The dosage and administration of this medication may vary depending on the individual's specific needs and medical condition.
Please consult with a healthcare professional for more information about Recombinant Antihemophilic Factor and its appropriate use.
Related Item Names for INC 50876 Recombinant Antihemophilic Factor
NATO Stock Numbers with Item Name 50876 Recombinant Antihemophilic Factor Page 1 of 1
- NOVO SEVEN
- RNCC: 5 | RNVC: 1 | DAC: 4
- KOGENATE FS 500 IU
- RNCC: 5 | RNVC: 2 | DAC: 4
- NDC 000260037220
- RNCC: 3 | RNVC: 2 | DAC: 4
- 000260037250
- RNCC: 3 | RNVC: 2 | DAC: 4
- B02BD02
- RNCC: 5 | RNVC: 9 | DAC: 9
- RECOMBINATE 1000 U.I.-10ML
- RNCC: 3 | RNVC: 2 | DAC: 4
- B02BD08
- RNCC: 6 | RNVC: 9 | DAC: 9
- 834 8914
- RNCC: 5 | RNVC: 2 | DAC: 4
- B02BD08
- RNCC: 6 | RNVC: 9 | DAC: 9